Toll-like receptor 4 and CD14 expression in human ciliary body and TLR-4 in human iris endothelial cells

被引:57
作者
Brito, BE
Zamora, DO
Bonnah, RA
Pan, YZ
Planck, SR
Rosenbaum, JT
机构
[1] Venezuelan Inst Sci Res, Cellular & Mol Pathol Lab, Ctr Med Expt, Caracas 1020A, Venezuela
[2] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Gene Therapy & Vaccine Inst, Portland, OR USA
关键词
ciliary body; CD14; endothelial cells; human; iris; toll-like receptor-4;
D O I
10.1016/j.exer.2004.03.012
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
We investigated the expression of the functional endotoxin receptor proteins Toll-like receptor-4 and CD14 in human eyes. Toll-like receptor-4 and CD14 proteins were detected by immunohistochemical analysis of sections of whole human eyes embedded in paraffin with monoclonal antibodies against human toll-like receptor-4 (HTA-125), human CD14 (RPA-M1), or as a control, an irrelevant mouse IgG1k (MOPC-21). Incubation of explants with a neutralizing anti-toll-like receptor-4 monoclonal antibody was used to determine if lipopolysaccharide stimulation of tumor necrosis factor or interleukin-6 secretion was dependent on Toll-like receptor-4 activity. Reverse transcription-polymerase chain reaction was used to detect mRNAs for toll-like receptor-4, tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8, 3 hr after stimulation of cultured iris microvascular endothelial cells. By immunohistochemistry, human ciliary body non-pigmented epithelial cells showed strong expression of the endotoxin receptor proteins, toll-like receptor-4 and CD14. Toll-like receptor-4 antibodies significantly inhibited lipopolysaccharide-stimulated tumor necrosis factor secretion by the ciliary body. Toll-like receptor-4 mRNA was constitutively expressed in iris endothelial cells and slightly down-regulated by endotoxin. mRNA levels for tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8 were all increased by endotoxin treatment. This is the first report that shows intraocular (ciliary body and iris) expression of toll-like receptor-4, other than in cornea. Our results show that the ciliary body also expresses CD14, which is anatomically colocalized with toll-like receptor-4. This suggests a potential interaction between both molecules during endotoxin activation of ciliary body cells. The juxtaposition of toll-like receptor-4 and CD 14 in the anterior uveal tract helps to explain the sensitivity of the iris/ciliary body to bacterial endotoxin as seen in the standard animal model of endotoxin-induced uveitis. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 37 条
[1]   PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES [J].
AARDEN, LA ;
DEGROOT, ER ;
SCHAAP, OL ;
LANSDORP, PM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1411-1416
[2]   Toll-like receptors in the induction of the innate immune response [J].
Aderem, A ;
Ulevitch, RJ .
NATURE, 2000, 406 (6797) :782-787
[3]   Cutting edge: Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages [J].
Akashi, S ;
Shimazu, R ;
Ogata, H ;
Nagai, Y ;
Takeda, K ;
Kimoto, M ;
Miyake, K .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3471-3475
[4]  
ARCHER JR, 1985, LANCET, V1, P344
[5]  
Baggia S, 1997, J INVEST MED, V45, P295
[6]   The effect of TNF-alpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo [J].
Bamforth, SD ;
Lightman, S ;
Greenwood, J .
ACTA NEUROPATHOLOGICA, 1996, 91 (06) :624-632
[7]   Expression of inflammatory cytokines in placentas from women with preeclampsia [J].
Benyo, DF ;
Smarason, A ;
Redman, CWG ;
Sims, C ;
Conrad, KP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (06) :2505-2512
[8]  
BRITO BE, UNPUB INCREASE LEVEL
[9]  
CANO M, UNPUBIRIS CILIARY BO
[10]   A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].
ESPEVIK, T ;
NISSENMEYER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105